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Introduction
Seizures are a common presenting feature in patientswith intracranial tumors, especially low grade glio-
mas1,8,17,18,19,20). The incidence of epilepsy associated with
brain tumors is approximately 35% when all locations and
histologic types are considered3,8,12). Although seizure is one
of the most frequent symptoms of brain tumors, its exact
pathogenesis is currently unknown. 
The critical factors responsible for the development of
epilepsy appear to be associated with the indolent growth
pattern and location of the lesion5,17,20). Seizures are more
common with the relatively slow growing tumors, e.g. low
grade astrocytomas, oligodendrogliomas, mixed oligodendr-
oastrocytomas, and gangliogliomas9). Many of the rapidly
growing gliomas predominantly involve the white matter and
appear to be less epileptogenic19,20). The chronic nature of a
mass lesion will often account for the adverse effects of the
tumor on the adjacent cortical neurons17), which occur mor-
phologically and biochemically in the form of neurotrans-
mitter alterations10). 
The present study was conducted under the assumption that
if the seizure foci form around the brain tumor as reported
above, more chronic epileptic patients would have stronger
aberrant neuronal network, thus more frequent postoperative
epilepsies. We compared the frequency of postoperative epil-
epsies with chronic as opposed to recent onset preoperative
epilepsies due to glial tumors in the frontal or temporal lobe
with the hypothesis that patients with chronic epilepsy do
worse.
Materials and Methods
Two hundred twenty-six patients(age range 32 to 71 ye-ars; 121 males and 105 females) with the glial tumor
were studied retrospectively as the subjects, who had under-
䤎Received：January 20, 2003  䤎Accepted：June 3, 2003
䤎Address for reprints：Jung Yong Ahn, M.D., Department of Ne-
urosurgery, Pundang CHA Hospital, Pochon CHA University, 351
Yatap-dong, Pundang-gu, Seongnam 463-712, Korea
Tel：031) 780-5263, Fax：031) 780-5269
E-mail：jyahn@cha.ac.kr
C
linical A
rticle
Significance of Chronic Epilepsy in Glial Tumors 
Jung   Yong   Ahn,   M.D.,1 Ok-Joon   Kim,   M.D.,2 Kyu   Sung   Lee,   M.D.,3 
Joong   Uhn   Choi,   M.D.,3 Sang   Sup   Chung,   M.D.,1 Byung-In   Lee,   M.D.4
Departments of Neurosurgery,1 Neurology,2 Pundang CHA Hospital, 
Pochon CHA University, Seongnam, Korea
Departments of Neurosurgery,3 Neurology,4 Yonsei University College of Medicine, Seoul, Korea 
Objective : The aim of this study is to compare the frequency of postoperative epilepsies of patients with
chronic as opposed to recent onset epilepsy due to glial tumors in the frontal or temporal lobe with the
hypothesis that patients with chronic epilepsy do worse. 
Methods : We compared the clinical and diagnostic characteristics of the patients(n=73) who had seizures
preoperatively to those of the patients(n=153) who did not. Among those who have had seizures preop-
eratively, we compared those(n=32, chronic seizure group) who had seizures a year or more prior to surgery
to those(n=41, acute seizure group) who had seizures within a year prior to surgery. 
Results : Among the various factors, the frequency of benign pathology and favorable neurological state were
higher in seizure group than in non-seizure group(p<0.05). Complex partial seizure and low-grade tumors
were frequent in chronic seizure group, whereas simple partial seizure and high-grade tumors were frequent in
acute seizure group. Seizure-free rate was significantly higher in acute seizure group than in chronic one
(p<0.05). Also, the difference of seizure control rate between surgical strategies were statistically significant(p
<0.05). 
Conclusion : This study indicates that preoperative seizure durations and frequencies have a close
relationship with the frequency of postoperative epilepsy of glial tumors. A longer lapse may allow the
formation of epileptogenic foci, leading to chronic epilepsy, and eventually having a negative effect on the
prognosis of the patients. Factors including histopathological characteristics of the tumor, its location, seizure
duration/frequency, and semiology should be taken account of deciding on surgical strategies.
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gone brain surgery from January 1995 to December 2001.
Exclusion criteria in this study are as follow; 1) operative or
postoperative mortality, 2) tumor locations except frontal and
temporal lobe, 3) tumor histopathology except ganglioglioma,
astrocytic gliomas, 4) positive family history of epilepsy, 5)
recurrent glial tumors. Demographic data, including age at
presurgical evaluation, age at seizure onset, duration and freq-
uency of seizure disorder, neurologic deficits at presentation,
and etiologic factors, were acquired from the medical records.
Laboratory tests at admission, fasting blood glucose and ser-
um electrolyte levels(calcium, magnesium, and sodium),
were reviewed. Based on the ictal semiology and EEG findi-
ngs, patient's seizures were classified as simple partial(simple
motor or sensory), simple partial with secondary generaliza-
tion, complex partial, complex partial with secondary gener-
alization, or primary generalized seizure. Chronic seizure was
defined as seizure occurring a year or more prior to surgery.
The following surgical procedures were performed : subtotal
tumor resection(n=62), focal tumor resection without seizure
foci mapping(n=109), radical tumor resection without seizure
foci mapping(n=43), and radical tumor removal with seizure
foci mapping(n=12). The term 'Radical tumor removal' was
defined that brain adjacent to the lesion was also included in
the resection strategy in addition to removing the tumor. 
The pathological diagnosis was classified as ganglioglioma
(grade I~II), pilocytic astrocytoma(grade I), diffuse astroc-
ytoma(grade II), anaplastic astrocytoma(grade III) and gliob-
lastoma(grade IV) according to World Health Organization
classification of the neuroepithelial tumors11). Of the 226 patie-
nts, 33 were diagnosed as grade I, 51 as grade II, 46 as grade
III, and 96 as grade IV.
The postoperative observation
periods ranged from 5 to 63 months
(mean, 29 months). With respect to
the postoperative seizure state, patients
were assigned to two different out-
come classes, seizurefree or not. 
Statistical analysis was perform-
ed by Student's t-test and cross
tabulation test using the Statistical
Package for Social Science Statv-
iew Package(SPSS Inc., Chicago,
IL, USA) with a p value < 0.05
considered statistically significant.
Results
Clinicopathological char-
acteristics of the patients with glial tumors
Clinicopathological profiles of the patients with glial tumors
related to seizures are listed in Table 1. There were a total of 226
patients, with 73 patients(32.3%) in seizure group, and 153
patients(67.7%) in non-seizure group. At time of operation,
patient's average age was 36.7 and 39.8 for seizure group and
non-seizure group, respectively, showing no significant
difference. Male to female ratio for seizure group was 48:25 and
for non-seizure group was 73:80, showing no significant
difference. The number of patients with neurological deficits on
admission was 112 for non-seizure group(73.2%), which were
considerably more than 18 for seizure group(24.7%). Tumors for
seizure group were more frequently observed in the temporal
lobe, whereas tumors for non-seizure group were commonly
involved in more than two adjacent cerebral cortexes. His-
topathological examination showed that anaplastic astrocytoma
and glioblastoma were more frequent in non-seizure group than
in seizure group, but the relatively frequent tumor pathology in
seizure group was ganglioglioma and diffuse astrocytoma(p<
0.05).
Clinicopathological profiles of the patients
with glial tumor-associated epilepsy
Seventy-three patients in seizure group were further divided in
chronic seizure group(seizure duration( 1 year, n=32) and
acute seizure group(seizure duration < 1 year, n=41).
Clinicopathological profiles of the patients with glial tumor-
associated epilepsy are listed in Table 2. In both groups there
were more males with sex ratios of 19:13 and 29:12 for chronic
and acute seizure groups respectively. Average age at the point
of operation was 33.2 and 36.3 in respective group. There was
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Table 1. Clinicopathological profiles of the patients with glial tumors related to seizures
Seizure (n=73) Non-seizure (n=153) p-value*
Age(mean, year) 36.7 39.8 0.452
Sex (male : female) 48:25 73:80 0.182
Neurological deficits on admission 18 (24.7%) 112 (73.2%) 0.014
Location of tumor
Frontal lobe 18 (24.7%) 50 (32.7%)
Temporal lobe 36 (49.3%) 34 (22.2%)
Adjacent two more cortexes** 19 (26.0%) 69 (45.1%)
Histopathology 0.024
Ganglioglioma (I~II) 5 (  6.8%) 0 (  0.0%)
Pilocytic astrocytoma (I) 6 (  8.2%) 22 (14.4%)
Diffuse astrocytoma (II) 36 (49.3%) 15 (  9.8%)
Anaplastic astrocytoma (III) 11 (15.1%) 35 (22.9%)
Glioblastoma (IV) 15 (20.6 %) 81 (52.9%)
* Student's t-test was used for a statistical comparison of continuous variables. Discrete variables were compared by cr-
oss tabulation tests, ** Adjacent two more cortexes included of fronto-temporal, fronto-parietal, temporo-parietal, and
fronto-temporoparietal areas
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no significant difference of age and sex between two groups. The
number of cases with abnormal laboratory findings at admission
was 6(18.8%) and 16(39.0%) in each group respectively, with no
significant difference between two groups. The number of cases
with neurological deficits on admission was 8(25.0%) and 10
(24.4%), with no significant difference between two groups. Ten
of 19 patients in chronic seizure group and 3 of 8 patients in
acute seizure group had interictal epileptiform discharges on
electroencephalography, with no significant difference. Tem-
poral lobe was the most frequent site for glial tumors in both
groups. Mean seizure duration was 18.4 and 3.6 months and
mean seizure frequency was 4.5 and 1.5 times/year in respective
group, with significant difference(p<0.05). As for seizure pa-
tterns, both groups had the highest number of primary gener-
alized seizure. Complex partial seizure and complex partial
seizure with secondary generalization were relatively frequent
seizure pattern in chronic seizure group, whereas simple partial
and simple partial with secondary generalization were relatively
common in acute seizure group. In histopathological exam-
ination of brain tumor, diffuse astrocytoma was more frequent in
chronic seizure group than in acute seizure group, and glioblas-
toma was more frequently observed in acute seizure group than
in chronic seizure group. However,
this difference between tumor grade
and seizure duration was not signif-
icant.
Seizure outcome related to
seizure duration and sur-
gical strategies
Table 3 shows the outcome of 73
patients with respect to seizure con-
trol. Seizure-free rate after surgery
was 62.5% in chronic seizure group,
whereas 82.9% in acute seizure
group. This difference of seizure co-
ntrol rate between two groups was
statistically significant(p<0.05).
With the surgical strategies, the most
favorable results were observed in
patients who underwent radical tu-
mor resection with seizure foci ma-
pping(seizure-free rate; 91.7%). The
ratio of seizure-free patients who
underwent incomplete tumor rese-
ction was lower(50%). Whereas 13
of 16 patients(81.3%) who under-
went radical tumor resection without
intraoperative monitoring became free of seizures, only 23 of 31
patients(74.3%) who underwent focal tumor resection without
seizure foci mapping was seizure-free. These differences were
stati-stically significant(p<0.05).
Discussion
Eeizure is one of the most frequent symptoms of brain tumorand many patients with benign supratentorial glioma are
first admitted to hospital with the seizure manifestation23). Cases
of malignant tumor manifesting as seizure is relatively rare,
however seizure is frequent during the clinical course, with about
60% of malignant glioma patients experiencing seizure13). Of a
lot of factors, the most important factor has been known as the
location of the tumor5,17 20). With respect to the tumor location,
22-68% of patients with supratentorial tumor experience
seizure6,21). The frequency of seizure is high in the superficial
area or cortex of tumor location, whereas low in deep subcortical
region12,24). In this study design, therefore, we focused on only
temporal or frontal cortex in tumor location. 
Seizure also has a correlation with the chronicity of tumor5,6,20).
Slowgrowing tumors such as benign astrocytoma, gangli-
Table 2. Clinicopathological profiles of the patients with glial tumor-associated epilepsy 
Chronic seizures (n=32) Acute seizures (n=41) p-value*
Age (mean, year) 33.2 36.3 0.432
Sex (male : female) 19:13 29:12 0.287
Laboratory abnormalities 6   (18.8%) 16   (39.0%) 0.065
Neurological deficits on admission 8   (25.0%) 10   (24.4%) 0.823
Interictal epileptiform discharges 55.5% (10/19) 37.5% (3/8) 0.083
on electroencephalography (%) 
Location of tumor
Frontal lobe 8   (25.0%) 10   (24.4%)
Temporal lobe 14   (43.7%) 22   (53.6%)
Adjacent two more cortexes** 10   (31.3%) 9   (22.0%)
Seizure duration (mean, months) 18.4 3.6 0.001
Seizure frequency (mean, times/year) 4.5 1.5 0.014
Semiology
Simple partial 3   (  9.4%) 7   (17.1%)
Simple partial with SGa 1   (  3.1%) 3   (  7.3%)
Complex partial 3   (  9.4%) 2   (  4.9%)
Complex partial with SGa 5   (15.6%) 0   (  0.0%)
Primary generalized seizure 20   (62.5%) 29   (70.7%)
Histopathology 0.062
Ganglioglioma (I~II) 4   (12.5%) 1   (  2.4%)
Pilocytic astrocytoma (I) 3   (  9.4%) 3   (  7.3%)
Diffuse astrocytoma (II) 20   (62.5%) 16   (39.0%)
Anaplastic astrocytoma (III) 3   (  9.4%) 8   (19.5%)
Glioblastoma (IV) 2   (  6.2%) 13   (31.8%)
* Student's t-test was used for a statistical comparison of continuous variables. Discrete variables were compared by cross
tabulation tests, ** Adjacent two more cortexes included of fronto-temporal, fronto-parietal, temporo-parietal, and
fronto-temporoparietal areas, a : secondary generalization
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oglioma, dysembryoplastic neuroe-
pithelial tumor have the high frequ-
ency of seizure24). Relatively fast-
growing tumors have reduced frequ-
ency of seizure12). In the present stu-
dy, patients with the low grade glio-
mas such as ganglioglioma and diff-
use astrocytoma experienced the
higher frequency of seizure disorder
than those with malignant glial tum-
ors such as anaplastic astrocytoma
and glioblastoma. The chronic nature of a mass lesion will often
account for the adverse effects of a tumor on the adjacent cortical
neurons17), which form abnormal local excitatory and inhibitory
neuronal circuits morphologically or occur in neurotransmitter
alterations biochemically10). It has also been demonstrated that
the hyperexcitable cortex surrounding the tumor nidus in low
grade gliomas has a significantly decreased population of -
aminobutyric acid and somatostatin containing neurons when
compared to adjacent non-tumor, non-epileptogenic cortex from
the same patient7). These reports support the hypothesis that the
mechanisms of seizure in malignant and benign tumors are
different. This study was focused on the chronicity of seizure and
was designed to compare the seizure control rate of patients with
chronic as opposed to recent onset seizure due to glial tumors
with the hypothesis that patients with chronic seizures do worse.
It has pragmatic value both to the clinical practitioner as well as
to the academic researcher for studying epileptogenesis in brain
tumors. This study set a period of one year as a criterion to
distinguish acute and chronic seizure groups, though this
standard is rather arbitrary. The period of a year was determined
as being long enough for an individual epileptogenic zone to be
formed around the brain tumor, considering that seizure fre-
quency is the highest within the first year of post-traumatic
epilepsy15). In reality, differences in clinical prognosis of the
patients classified with this standard could be observed in the
results of this study. 
Understanding the spatial and causal relationships between
structural lesions and epilepsy is essential to rational therapeutic
strategies. Although there may be evidence to support the
concept of separate seizure foci surrounding a tumor14,17),
controversy exists as to whether it is essential to include these
peripheral epileptogenic zones in the surgical resection.
Favorable results have been reported after lesionectomy, with a
percentage of seizure-free patients ranging from 65 to
80%2,4,8,16,20). They suggest that the cortex surrounding the tumor
loses the ability to independently initiate and propagate seizures
once the tumor itself has been removed14,19). Others noted the
importance of defining and extirpating the epileptogenic
zone2,4,16,20,22). Accordingly, the resection of the epileptogenic
zone in patients with tumor-associated epilepsy provided a high
level of postoperative seizure control. Affirmatively, in our patie-
nts, seizure control was better if the zone of seizure origin and
the zone of maximal interictal spiking were completely excised. 
However, the available literature on the question of whether
excision of the epileptogenic brain area results in a better seizure
control than lesionectomy alone is heterogeneous with regard to
tumor location, tumor type, and the degree of malignancy of the
tumors; the data and conclusions are conflicting2,8,20,22). This
question is important, particularly because of the high costs of
intraoperative monitoring and the need to refer patients to sophi-
sticated epilepsy centers2). Thus, our study has a high signifi-
cance in indicating guidelines for decision of surgical strategies.
Seizure-free rate after surgery was 82.9% in acute seizure group
composed of tumors with a high-grade relatively, with a high
percentage of seizure control rate. Therefore, we suggest that
lesionectomy alone is sufficient in patients with tumor-associated
with acute seizure, especially in malignant tumors. Radical res-
ection without intraoperative monitoring was also recommended
if tumor is located on non-functional areas. On the other hand,
only 62.5% of patients in chronic seizure group were seizure-
free, with a lower percentage than in acute seizure group. We
recommend that additional resection of the epileptogenic zone is
required to achieve optimal seizure control in chronic seizure
group, especially in low-grade gliomas. 
Conclusion
This study indicates that the longer seizures persist, thepoorer prognosis is. In cases of low-grade gliomas, a
longer lapse allows formation of epileptogenic foci, leading to
chronic epilepsy, and eventually having negative effect on the
prognosis of the patients. Thus, the management of patients
with chronic seizure associated with low-grade gliomas has
included identification and resection, when possible, of the
Table 3. Seizure outcome related to seizure duration and surgical strategies
Seizure-free (n=54) Seizure recur (n=19) p-value*
Seizure duration 0.028
Chronic ( ≥ 1 year) (n=32) 20 12
Acute ( < 1 year) (n=41) 34 7
Surgical strategies 0.012
Subtotal tumor resection (n=14) 7 7
Focal tumor resection without SFMa (n=31) 23 8
Radical tumor resection without SFMa (n=16) 13 3
Radical tumor resection with SFMa (n=12) 11 1
a : seizure foci mapping
seizure foci in addition to performing a complete tumor
removal. The standard of chronic seizure was established a
period of one year in this study, but is rather arbitrary. Further
clinical studies will provide useful information. 
Complete resection of tumors provides the most important
condition for seizure relief. Others including histopatholo-
gical characteristics, location of the tumor, and semiology sh-
ould be taken account of deciding on surgical strategies.
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